Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model

International Journal of Cardiology

Volumn 198, Issue , 2015, Pages 187-195

  Han, Yong Seok ^a   Lee, Jun Hee ^b   Jung, Jin Sup ^b,c   Noh, Hyunjin ^a   Baek, Moo Jun ^a   Ryu, Jung Min ^d   Yoon, Yeo Min ^a   Han, Ho Jae ^d   Lee, Sang Hun ^a  

^a Soonchunhyang University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Fucoidan; MnSOD; MSCs; Survival; Vascular repair

Indexed keywords

CASPASE 3; CELLULAR INHIBITOR OF APOPTOSIS; FUCOIDIN; HYDROGEN PEROXIDE; INHIBITOR OF APOPTOSIS PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; SIGNAL TRANSDUCTION; VASCULAR REGENERATION; ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; DOSE RESPONSE; DRUG EFFECTS; HINDLIMB; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; HUMANS; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; POLYSACCHARIDES;

EID: 84940395567     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.070     Document Type: Article

References (27)

1. M.E. Castro-Manrreza, and J.J. Montesinos Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications J. Immunol. Res. 2015 2015 394917
2. A. Monsel, Y.G. Zhu, S. Gennai, Q. Hao, J. Liu, and J.W. Lee Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells Anesthesiology 121 2014 1099 1121
3. V.K. Morya, J. Kim, and E.K. Kim Algal fucoidan: structural and size-dependent bioactivities and their perspectives Appl. Microbiol. Biotechnol. 93 2012 71 82
4. K. Senthilkumar, P. Manivasagan, J. Venkatesan, and S.K. Kim Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer Int. J. Biol. Macromol. 60 2013 366 374
5. J.Y. Kwak Fucoidan as a marine anticancer agent in preclinical development Mar. Drugs 12 2014 851 870
6. G. Sarlon, F. Zemani, L. David, J.P. Duong Van Huyen, B. Dizier, F. Grelac, and et al. Therapeutic effect of fucoidan-stimulated endothelial colony-forming cells in peripheral ischemia J. Thromb. Haemost. 10 2012 38 48
7. J.H. Lee, S.H. Lee, S.H. Choi, T. Asahara, and S.M. Kwon The sulfated polysaccharide fucoidan rescues senescence of endothelial colony-forming cells for ischemic repair Stem Cells 33 2015 1939 1951
8. A. Limbourg, T. Korff, L.C. Napp, W. Schaper, H. Drexler, and F.P. Limbourg Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia Nat. Protoc. 4 2009 1737 1746
9. H. Niiyama, N.F. Huang, M.D. Rollins, and J.P. Cooke Murine model of hindlimb ischemia J. Vis. Exp. 2009
10. A. Hidalgo, A.J. Peired, L.A. Weiss, Y. Katayama, and P.S. Frenette The integrin alphaMbeta2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization Blood 104 2004 993 1001
11. W. Guo, and F.G. Giancotti Integrin signalling during tumour progression Nat. Rev. Mol. Cell Biol. 5 2004 816 826
12. Z.J. Wang, F.M. Zhang, L.S. Wang, Y.W. Yao, Q. Zhao, and X. Gao Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor (TLR)-4 and PI3K/Akt Cell Biol. Int. 33 2009 665 674
13. J.M. Hare, J.E. Fishman, G. Gerstenblith, D.L. DiFede Velazquez, J.P. Zambrano, V.Y. Suncion, and et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial JAMA 308 2012 2369 2379
14. V. Karantalis, D.L. DiFede, G. Gerstenblith, S. Pham, J. Symes, J.P. Zambrano, and et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial Circ. Res. 114 2014 1302 1310
15. V.Y. Suncion, E. Ghersin, J.E. Fishman, J.P. Zambrano, V. Karantalis, N. Mandel, and et al. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: an analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial Circ. Res. 114 2014 1292 1301
16. T.E. Robey, M.K. Saiget, H. Reinecke, and C.E. Murry Systems approaches to preventing transplanted cell death in cardiac repair J. Mol. Cell. Cardiol. 45 2008 567 581
17. H. Haider, and M. Ashraf Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation J. Mol. Cell. Cardiol. 45 2008 554 566
18. W. Zhu, J. Chen, X. Cong, S. Hu, and X. Chen Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells Stem Cells 24 2006 416 425
19. J. Chen, A.R. Baydoun, R. Xu, L. Deng, X. Liu, W. Zhu, and et al. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis Stem Cells 26 2008 135 145
20. Y.J. Cao, T. Shibata, and N.G. Rainov Hypoxia-inducible transgene expression in differentiated human NT2N neurons - a cell culture model for gene therapy of postischemic neuronal loss Gene Ther. 8 2001 1357 1362
21. G. Wang, T.K. Hazra, S. Mitra, H.M. Lee, and E.W. Englander Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells Nucleic Acids Res. 28 2000 2135 2140
22. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell Biol. 39 2007 44 84
23. T. Shibata, K. Ishimaru, S. Kawaguchi, H. Yoshikawa, and Y. Hama Antioxidant activities of phlorotannins isolated from Japanese Laminariaceae J. Appl. Phycol. 20 2008 705 711
24. S.H. Lee, M.H. Park, S.J. Heo, S.M. Kang, S.C. Ko, J.S. Han, and et al. Dieckol isolated from Ecklonia cava inhibits alpha-glucosidase and alpha-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice Food. Chem. Toxicol. 48 2010 2633 2637
25. S. Shastry, A.J. Ingram, J.W. Scholey, and L.R. James Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase Kidney Int. 71 2007 304 311
26. Y. Li, F. Xue, S.Z. Xu, X.W. Wang, X. Tong, and X.J. Lin Lycopene protects bone marrow mesenchymal stem cells against ischemia-induced apoptosis in vitro Eur. Rev. Med. Pharmacol. Sci. 18 2014 1625 1631
27. J.F. Deux, A. Meddahi-Pelle, A.F. Le Blanche, L.J. Feldman, S. Colliec-Jouault, F. Bree, and et al. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model Arterioscler. Thromb. Vasc. Biol. 22 2002 1604 1609